ATE318075T1 - Hepatoblasten und verfahren zu ihrer isolierung - Google Patents

Hepatoblasten und verfahren zu ihrer isolierung

Info

Publication number
ATE318075T1
ATE318075T1 AT95903543T AT95903543T ATE318075T1 AT E318075 T1 ATE318075 T1 AT E318075T1 AT 95903543 T AT95903543 T AT 95903543T AT 95903543 T AT95903543 T AT 95903543T AT E318075 T1 ATE318075 T1 AT E318075T1
Authority
AT
Austria
Prior art keywords
hepatoblasts
methods
isolation
relates
well
Prior art date
Application number
AT95903543T
Other languages
English (en)
Inventor
Lola M Reid
Samuel H Sigal
Shlomo Brill
Patricia A Holst
Original Assignee
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med filed Critical Einstein Coll Med
Application granted granted Critical
Publication of ATE318075T1 publication Critical patent/ATE318075T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95903543T 1993-11-19 1994-11-16 Hepatoblasten und verfahren zu ihrer isolierung ATE318075T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15593993A 1993-11-19 1993-11-19

Publications (1)

Publication Number Publication Date
ATE318075T1 true ATE318075T1 (de) 2006-03-15

Family

ID=22557387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95903543T ATE318075T1 (de) 1993-11-19 1994-11-16 Hepatoblasten und verfahren zu ihrer isolierung

Country Status (10)

Country Link
EP (2) EP0729297B1 (de)
JP (2) JPH09505206A (de)
AT (1) ATE318075T1 (de)
AU (1) AU1256395A (de)
CA (1) CA2177043C (de)
DE (1) DE69434637T2 (de)
ES (1) ES2260759T3 (de)
IL (1) IL111693A (de)
WO (1) WO1995013697A1 (de)
ZA (1) ZA949180B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0953633A1 (de) * 1998-04-28 1999-11-03 Livercell L.L.C. Zellkulturverfahren und Medium zur Herstellung von vermehrungsfähige, normale, differenzierte Humane Leberzellen
EP1147179B1 (de) * 1999-01-19 2008-11-12 The University of North Carolina at Chapel Hill Menschliche leber-vorläuferzellen
US7456017B2 (en) 1999-10-01 2008-11-25 University Of North Carolina At Chapel Hill Processes for clonal growth of hepatic progenitor cells
US20020187133A1 (en) 1999-10-01 2002-12-12 Hiroshi Kubota Methods of isolating bipotent hepatic progenitor cells
AU782683B2 (en) * 2000-01-19 2005-08-18 University Of North Carolina At Chapel Hill, The Liver tissue source
IL155387A0 (en) * 2000-10-03 2003-11-23 Univ North Carolina Processes for clonal growth of hepatic progenitor cells
JP4499990B2 (ja) 2001-03-27 2010-07-14 バーテックス ファーマシューティカルズ インコーポレイテッド Ｈｃｖ感染に有用な組成物および方法
EP2388330B1 (de) * 2001-06-22 2015-05-20 StemCells, Inc. Zellen zur Einpflanzung in die Leber, Assays dafür und Verwendungen davon
CN1742082B (zh) * 2002-03-15 2015-01-21 北卡罗来纳大学查伯山分校 原肝干细胞和近肝干细胞
CN113046304B (zh) * 2021-04-09 2023-05-16 四川大学华西医院 一种线粒体的分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition
JPH07501206A (ja) * 1991-08-07 1995-02-09 イェシバ・ユニバーシティ 前駆肝細胞の増殖
KR950703640A (ko) * 1992-10-09 1995-09-20 가일 케이,나우톤. 간 보존 세포(liver reserve cells)

Also Published As

Publication number Publication date
WO1995013697A1 (en) 1995-05-26
IL111693A (en) 2001-01-28
EP0729297B1 (de) 2006-02-22
DE69434637D1 (de) 2006-04-27
JPH09505206A (ja) 1997-05-27
DE69434637T2 (de) 2006-09-21
JP2004339227A (ja) 2004-12-02
IL111693A0 (en) 1995-01-24
EP1688037A3 (de) 2006-12-13
EP1688037A2 (de) 2006-08-09
AU1256395A (en) 1995-06-06
CA2177043C (en) 2011-08-09
EP0729297A1 (de) 1996-09-04
EP0729297A4 (de) 2004-05-06
CA2177043A1 (en) 1995-05-26
ZA949180B (en) 1995-07-26
ES2260759T3 (es) 2006-11-01

Similar Documents

Publication Publication Date Title
DE69425372D1 (de) Verfahren zur behandlung endo-ostealer materialien
DE69624729T2 (de) Verfahren zur selektiven öffnung von naphtalinringen
DK94588A (da) Metode til behandling af slam fra spildevand
ATA121293A (de) Verfahren zum herstellen von kaltgepressten eisenhältigen briketts
DE69534886D1 (de) Verfahren zur Isolierung von Zellkomponenten
ATE318075T1 (de) Hepatoblasten und verfahren zu ihrer isolierung
DE69003944D1 (de) Verfahren zur gesteuerten anaeroben zersetzung von abfall.
DE69302810T2 (de) Verbundwerkstoffe und verfahren zu ihrer herstellung
DE69425497D1 (de) Verfahren zum anreichern von löslichen ballaststoffen
ATE204120T1 (de) Verfahren zur vermehrung von pflanzenmaterial
DE69605902D1 (de) Verfahren zur stabilisierung von schlamm
DE69533590D1 (de) Verfahren zur herstellung von feinteiligen festen builderpartikeln
DE69419991D1 (de) Verfahren zum Fassen von Schmuck
DE59611017D1 (de) Verfahren zur herstellung von n-substituierten 3-hydroxypyrazolen
ATE174954T1 (de) Verfahren zur herstellung von granularen waschmittelkomponenten oder waschmittelzusammensetzungen
DE59807503D1 (de) Verfahren zur herstellung von erdalkalidiorganylverbindungen
ATA214793A (de) Verfahren zur erzeugung von erde
DE69402880D1 (de) Verfahren zur herstellung von alkylglykosiden
ATE223259T1 (de) Verfahren zur wiedergewinnung von sekundärrohstoffen aus restmüll und reststoffen
ATA181993A (de) Verfahren zur umweltgerechten entsorgung von triazinabfällen
DE59602249D1 (de) Verfahren zur grobklassifizierung von objekten
DE19711103B4 (de) Verfahren zum Verformen von Bauelementen durch Einwirkung magnetischer Kräfte
DE69403611T2 (de) Verfahren zur herstellung von homogenem magnetit
DE69621261D1 (de) Verfahren zum Herstellen von Beuteln
DE69624730D1 (de) Verfahren zur selektiven spaltung von naphthalin-ringen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0729297

Country of ref document: EP

REN Ceased due to non-payment of the annual fee